Skip to main content
Log in

The new histamine H2-receptor antagonist ranitidine

Duration of Action

  • Original Contributions
  • Published:
Research in Experimental Medicine

Summary

The antisecretory effects of a new histamine H2-receptor antagonist, ranitidine hydrochloride, have been investigated on basal and pentagastrinstimulated acid secretion in healthy volunteers 5 and 10 h after oral administration of 150 mg. In addition, the 24-h intragastric pH-profiles have been measured in patients undergoing parenteral nutrition after three doses of 150 mg ranitidine per day.

A 40% inhibition of basal acid output has been noted even 10 h after drug intake. The intragastric pH-values were raised above 5 for at least 24h.

The new H2-antagonist ranitidine has been proven to be a potent and longacting antisecretory compound.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brittain RT, Daly MJ (1980) A review of the animal pharmacology of ranitidine—a new selective histamine H2-antagonist. Paper read at Drug Symposium on Ranitidine, Hamburg 14th June

  2. Bohman T, Myren J, Larsen S (1980) Inhibition of histamine-stimulated gastric acid secretion in healthy subjects by the H2-receptor antagonist ranitidine. Scand J Gastroenterol 15:183–185

    PubMed  Google Scholar 

  3. Daly MJ, Humphray JM, Stables R (1980) Inhibition of gastric acid secretion in the dog by the H2-receptor antagonists, ranitidine, cimetidine, and metiamide. Gut 21:408–412

    PubMed  Google Scholar 

  4. Dammann HG, Kather H, Augustin JH, Simon B (1980) Untersuchungen über die Wirkdauer von Ranitidin. Dtsch Med Wochenschr 105:603–605

    PubMed  Google Scholar 

  5. Domschke W, Lux G, Domschke S (1979) Gastric inhibitory action of H2-receptor antagonists ranitidine and cimetidine. Lancet 1:320

    Google Scholar 

  6. Kett K, Aadland E, Betstadt A (1980) Inhibition of gastric acid secretion in man with a new H2-receptor antagonist ranitidine. Scand J Gastroenterol 15:249–251

    PubMed  Google Scholar 

  7. Konturek SJ, Obtulowicz W, Kwiecien N, Sito E, Mikos E, Olesky J (1980) Comparison of ranitidine and cimetidine in the inhibition of histamine-, sham-feeding-, and meal-induced gastric acid secretion in duodenal ulcer patients. Gut 21:181–186

    PubMed  Google Scholar 

  8. Peden NR, Saunders JHB, Wormsley KG (1979) Inhibition of pentagastrin-stimulated and nocturnal gastric acid secretion by ranitidine. Lancet 1:690–692

    PubMed  Google Scholar 

  9. Simon B, Kather H (1979) Hemmung der pentagastrin-stimulierten Magensekretion durch Ranitidin. Dtsch Med Wochenschr 104:1676–1678

    PubMed  Google Scholar 

  10. Walt RP, Male PJ, Rawlings J, Tovrie P, Hunt RH, Misiewicz JJ, Milton-Thompson GJ (1979) 24-h intragastric acidity in duodenal ulcer patients on a new twice-daily H2-receptor antagonist. Gut 20:A 904

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dammann, H.G., Müller, P., Kather, H. et al. The new histamine H2-receptor antagonist ranitidine. Res. Exp. Med. 178, 151–154 (1981). https://doi.org/10.1007/BF01851489

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01851489

Key words

Navigation